Another Kid on the Block: Long-acting FGF21 Analogue to Treat Dyslipidemia and Fatty Liver

被引：5
|
作者：
Yang, Ranyao [1 ,2 ]
Xu, Aimin [1 ,2 ,3 ]
Kharitonenkov, Alexei [4 ]
机构：
[1] Univ Hong Kong, State Key Lab Pharmaceut Biotechnol, Pokfulam, Hong Kong 999077, Peoples R China
[2] Univ Hong Kong, Dept Med, Pokfulam, Hong Kong 999077, Peoples R China
[3] Univ Hong Kong, Dept Pharmacol & Pharm, Pokfulam, L8-39,Lab Block,21 Sassoon Rd, Hong Kong 999077, Peoples R China
[4] AK Biotechnol LLC, 430 Amador Ln, W Palm Beach, FL 33401 USA
来源：
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM | 2022年 / 107卷 / 01期
关键词：
fibroblast growth factor 21 (FGF21); hypertriglyceridemia; obesity; nonalcoholic fatty liver diseases (NAFLD); metabolism;
D O I：
10.1210/clinem/dgab686
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：E417 / E419
页数：3
相关论文
共 50 条
  • [41] Hepatic regulation of VLDL receptor by PPAR β/δ and FGF21 modulates non-alcoholic fatty liver disease
    Zarei, Mohammad
    Barroso, Emma
    Palomer, Xavier
    Dai, Jianli
    Rada, Patricia
    Quesada-Lopez, Tania
    Escola-Gil, Joan Caries
    Cedo, Lidia
    Zali, Mohammad Reza
    Molaei, Mahsa
    Dabiri, Reza
    Vazquez, Santiago
    Pujol, Eugenia
    Valverde, Angela M.
    Villarroya, Francesc
    Liu, Yong
    Wahli, Walter
    Vazquez-Camera, Manuel
    [J]. MOLECULAR METABOLISM, 2018, 8 : 117 - 131
  • [42] A Long-Acting FGF21 Molecule, PF-05231023, Decreases Body Weight and Improves Lipid Profile in Non-human Primates and Type 2 Diabetic Subjects
    Talukdar, Saswata
    Zhou, Yingjiang
    Li, Dongmei
    Rossulek, Michelle
    Dong, Jennifer
    Somayaji, Veena
    Weng, Yan
    Clark, Ronald
    Lanba, Adhiraj
    Owen, Bryn M.
    Brenner, Martin B.
    Trimmer, Jeffrey K.
    Gropp, Kathryn E.
    Chabot, Jeffrey R.
    Erion, Derek M.
    Rolph, Timothy P.
    Goodwin, Bryan
    Calle, Roberto A.
    [J]. CELL METABOLISM, 2016, 23 (03) : 427 - 440
  • [43] Engineering and Characterization of an Aggregation-and Proteolysis-Resistant Long-Acting Fc-FGF21 Analog
    Hecht, Randy
    Li, Yue-Sheng
    Sun, Jeonghoon
    Belouski, Ed
    Hall, Michael
    Hager, Todd
    Yie, Junming
    Wang, Wei
    Winters, Dwight
    Smith, Stephen
    Tam, Lei-Ting
    Shen, Zhongnan
    Stanislaus, Shanaka
    Chinookoswong, Narumol
    Michaels, Mark
    Boone, Thomas
    Veniant, Murielle M.
    Xu, Jing
    [J]. DIABETES, 2012, 61 : A246 - A246
  • [44] Metformin Prevents Fatty Liver and Improves Balance of White/Brown Adipose in an Obesity Mouse Model by Inducing FGF21
    Kim, Eun Kyung
    Lee, Seung Hoon
    Jhun, Joo Yeon
    Byun, Jae Kyeong
    Jeong, Jeong Hee
    Lee, Seon-Young
    Kim, Jae Kyung
    Choi, Jong Young
    Cho, Mi-La
    [J]. MEDIATORS OF INFLAMMATION, 2016, 2016
  • [45] YH25724, a Novel Long-Acting GLP-1/FGF21 Dual Agonist, Exhibits Marked Anti-Fibrotic Effects in a Rat Model of Established Thioacetamide-Induced Liver Fibrosis
    Kim, Tae Wang
    Kim, Junhwan
    Hong, Han Na
    Choi, Hyun Ho
    Kim, Do-Hoon
    Yang, Ji-Eun
    Jeong, Da-Na
    Ju, Mi Kyeong
    Seo, Minji
    Kim, Su Kyung
    Park, Ju-Young
    Choi, Byung Hyun
    Kim, Han-Joo
    Ahn, Kyoung Kyu
    Kim, Jong Gyun
    Ratziu, Vlad
    Oh, Se-Woong
    Choi, Soongyu
    [J]. HEPATOLOGY, 2018, 68 : 434A - 435A
  • [46] Alcoholic fatty liver is enhanced in CYP2A5 knockout mice: The role of the PPARα-FGF21 axis
    Chen, Xue
    Ward, Stephen C.
    Cederbaum, Arthur I.
    Xiong, Huabao
    Lu, Yongke
    [J]. TOXICOLOGY, 2017, 379 : 12 - 21
  • [47] Regeneration of Non-Alcoholic Fatty Liver Cells Using Chimeric FGF21/HGFR: A Novel Therapeutic Approach
    Kim, Sung-Jun
    Kim, So-Jung
    Hyun, Jeongeun
    Kim, Hae-Won
    Jang, Jun-Hyeog
    [J]. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2024, 25 (06)
  • [48] Hydrodynamic delivery of FGF21 gene alleviates obesity and fatty liver in mice fed a high-fat diet
    Gao, Mingming
    Ma, Yongjie
    Cui, Ran
    Liu, Dexi
    [J]. JOURNAL OF CONTROLLED RELEASE, 2014, 185 : 1 - 11
  • [49] Next Generation of FGF-21 Analogs: Engineered Short-and Long-Acting FGF-21 Variants with Improved In Vivo Potency, Stability, and Biopharmaceutical Properties
    Gonciarz, Malgorzata
    Driver, David
    Dickinson, Craig D.
    Ford, Amy
    Morehead, Teresa A.
    Dunbar, James D.
    Baker, Hana E.
    O'Farrell, Libbey S.
    Murphy, Anthony T.
    Hansen, Ryan J.
    Adams, Andrew C.
    Coskun, Tamer
    Darling, Ryan
    [J]. DIABETES, 2017, 66 : A530 - A530
  • [50] YH25724, a novel long-acting GLP-1/FGF21 dual agonist improves hepatic steatosis, inflammation and fibrosis in nonalcoholic steatohepatitis (NASH) animal models
    Kim, Jun Hwan
    Hong, Han Na
    Choi, Hyun Ho
    Kim, Dohoon
    Kim, Tae Wang
    Lim, Seyoung
    Seo, Minji
    Ju, Mi Kyeong
    Park, Ju-Young
    Choi, Byung Hyun
    Tolbol, Kirstine S.
    Feigh, Michael
    Vrang, Niels
    Kim, Jong Gyun
    Nam, Su Youn
    [J]. HEPATOLOGY, 2016, 64 (06) : 1136A - 1137A
12345